Aura's Nano-Based Delivery Attracts Funding, NCI Deal
By Jennifer Boggs
Friday, September 9, 2011
Figuring out how to get chemotherapy directly into tumor cells while sparing healthy cells has long been one focus of cancer drug development. The trick is developing a targeted drug delivery vehicle that's actually capable of penetrating cells.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.